We serve Chemical Name:2-methoxy-1-piperazin-1-ylethanone CAS:95550-06-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-methoxy-1-piperazin-1-ylethanone
CAS.NO:95550-06-4
Synonyms:2-methoxy-1-piperazin-1-yl-ethanone;N-ethoxycarbonylpiperazine;4-methoxyacetyl-piperazine
Molecular Formula:C7H14N2O2
Molecular Weight:158.19800
HS Code:2933599090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:41.57000
Exact Mass:158.10600
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-methoxy-1-piperazin-1-yl-ethanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-methoxyacetyl-piperazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-methoxyacetyl-piperazine Use and application,2-methoxy-1-piperazin-1-yl-ethanone technical grade,usp/ep/jp grade.
Related News: OTL-101, by comparison, is designed to correct the problem by inserting working copies of the gene into a patient’s blood stem cells. (13S,17S)-17-(1-Hydroxy-propyl)-13,17-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one manufacturers In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. N-[1-(1,4-benzodioxan-2-ylmethyl)piperidin-4-yl]-5-thia-1,8b-diazaacenaphthylene-4-carboxamide suppliers The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production. 4′-nitro-3-(1-phenyl-1H-tetrazol-5-ylsulfanyl)-biphenyl-2,5-dione vendor & factory.
